Copart Interest Paid increased by 19.2% to $764.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 43.9%, from $1.36M to $764.00K. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -43.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.12M | $4.99M | $5.08M | $4.23M | $5.17M | $4.05M | $64.00K | $642.00K | $880.00K | $1.03M | $96.00K | $1.94M | -$90.00K | $1.18M | $10.00K | $1.36M | $601.00K | $47.00K | $641.00K | $764.00K |
| QoQ Change | — | -30.0% | +1.9% | -16.7% | +22.3% | -21.6% | -98.4% | +903.1% | +37.1% | +16.8% | -90.7% | >999% | -104.6% | >999% | -99.2% | >999% | -55.8% | -92.2% | >999% | +19.2% |
| YoY Change | — | — | — | — | -27.4% | -18.7% | -98.7% | -84.8% | -83.0% | -74.6% | +50.0% | +202.2% | -110.2% | +14.9% | -89.6% | -29.8% | +767.8% | -96.0% | >999% | -43.9% |